GlassScriptPhysician profile
Weiyuan Tian
NPI 1538736921
$4,612.71
in general payments reported to CMS, 2019-2025
16 companies · $2,899 in 2025
The $2,899 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $891 · 2023: $310 · 2024: $513 · 2025: $2,899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,657 · Travel and Lodging: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,657.44 |
| Travel and Lodging | $1,064.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,269.12 | 2022-2024 | Citrefix, Prostep, Ortholoc 3di |
| Paladin Technology Solutions | $1,031.65 | 2024-2025 | |
| Arthrex, INC. | $696.40 | 2025 | |
| Treace Medical Concepts, INC. | $344.04 | 2025 | |
| Smith+Nephew, INC. | $293.50 | 2022-2025 | Oasis Micro, Stravix Mesh, Grafix Pl |
| Paragon 28, INC. | $149.03 | 2025 | Phantom Fibula Nail |
| Vertex Pharmaceuticals Incorporated | $148.43 | 2025 | |
| Abbvie INC. | $142.51 | 2025 | |
| Integra Lifesciences Corporation | $133.35 | 2022 | |
| Organogenesis INC. | $112.97 | 2025 | Simplimax |
| Alexion Pharmaceuticals, INC. | $90.94 | 2022 | |
| Paratek Pharmaceuticals, INC. | $59.27 | 2025 | Nuzyra |
| Averitas Pharma INC. | $54.04 | 2024 | Qutenza |
| Coastal Medical Technologies LLC | $44.77 | 2025 | |
| Eclipse Technology Solutions INC. | $27.62 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $15.07 | 2025 | Urgoclean Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weiyuan Tian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.